← Back to Search

Nonsteroidal Anti-inflammatory Drug

A 2 for Osteoarthritis

Phase 2
Waitlist Available
Led By Nora G Singer, MD
Research Sponsored by University Hospitals Cleveland Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

The purpose of this study is to compare the efficacy of celecoxib versus placebo in delaying the onset of pain and improving walking function in subjects with knee Osteoarthritis

Eligible Conditions
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: A 2Active Control1 Intervention
A 2=celecoxib
Group II: A 1Placebo Group1 Intervention
A 1=placebo

Find a Location

Who is running the clinical trial?

University Hospitals Cleveland Medical CenterLead Sponsor
320 Previous Clinical Trials
339,958 Total Patients Enrolled
4 Trials studying Osteoarthritis
199 Patients Enrolled for Osteoarthritis
Nora G Singer, MDPrincipal InvestigatorUniversity Hospitals Cleveland Medical Center
1 Previous Clinical Trials
43 Total Patients Enrolled
~1 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top